02.1 NADH vs NAD+

NADH vs NAD+: the reduced and oxidised forms

Technical document 02.1 · Reviewed 2026-11-20 · NADH

On this page
  1. The nicotinamide ring carries the change
  2. The two catalog materials side by side
  3. Detection wavelength is the practical separator
  4. Each form has its own decomposition route
  5. Converting mass is not converting the ingredient
  6. Which form the project should buy

NADH is the reduced member of the NAD redox pair and NAD+ the oxidised one; the difference is two electrons and a proton on the nicotinamide ring. Buyers meet them as different specifications: CAS 606-68-8 against 53-84-9, a 340 nm assay against a 260 nm assay, and a solid that loses reduced content in air against one that hydrolyses in water. A label, a certificate and a formulation cannot swap one for the other.

In one line

NADH and NAD+ are one redox step apart, and that step decides the CAS number, the wavelength the assay reads, the way each powder fails and the name on the label.

The nicotinamide ring carries the change

NAD+ presents a pyridinium cation on that ring; reduction converts it to a 1,4-dihydropyridine. Two electrons arrive with one proton, the hydride shift that dehydrogenases run in reverse. The rest of the coenzyme, the adenine, the two riboses and the pyrophosphate link, is common to both, which explains why the two powders look alike and behave unlike each other.

Compare like with like. The free acids are C21H27N7O14P2 at 663.43 for NAD+ and C21H29N7O14P2 at 665.45 for NADH: two hydrogen atoms, 2.02 mass units. The catalog materials are not matched that way. NADH is sold here as the disodium salt, C21H27N7Na2O14P2 at 709.40, while NAD+ is the free acid. Setting the two catalog numbers side by side mixes a salt with an acid and adds 45.97 mass units, of which 43.96 come from replacing two protons with two sodium ions.

The pair is not a ladder. NADH is not a stronger or purer NAD+, and NAD+ is not an earlier version of NADH. Each has its own certificate, assay and specification, and each is bought for the form it names.

The two catalog materials side by side

NADH disodium (reduced) and NAD+ free acid (oxidised)
PropertyNADH (reduced)NAD+ (oxidised)
CAS number606-68-853-84-9
Redox stateReducedOxidised
Nicotinamide ring1,4-DihydropyridinePyridinium
Catalog formDisodium salt, 709.40Free acid, 663.43
Ultraviolet maximaAbout 259 nm and 340 nmAbout 259 nm; no 340 nm band
Assay channel340 nmAbout 260 nm
Dominant solution reactionOxidation back to NAD+Hydrolysis
pH windowAcid-labile; handled alkalineMore stable mildly acidic
Ingredient nameReduced nicotinamide adenine dinucleotide disodium saltβ-Nicotinamide adenine dinucleotide

The table separates two materials that share a name stem, a biological role and most of their structure. It is not a conversion chart.

Detection wavelength is the practical separator

The reduced ring absorbs at 340 nm; the oxidised ring does not. A 340 nm HPLC method therefore reports NADH and is blind to NAD+. A 260 nm method sees the adenine ring in both forms, plus AMP, ADP and other nucleotides, so without chromatographic separation it reports a family rather than a compound.

A certificate that gives only a 340 nm percentage has not bounded the oxidised fraction. Ask for the 260 nm related-substance chromatogram and the NAD+ limit alongside it. In the other direction, a 260 nm assay presented as an NADH figure overstates the reduced content whenever NAD+ is present.

Activity is a third measurement. An enzymatic assay follows the 340 nm decrease as a dehydrogenase consumes NADH; that is a measure of coenzyme function, not of peak purity, and it sits beside the chromatogram rather than replacing it.

Each form has its own decomposition route

Oxygen takes NADH back to NAD+, a reaction that light, heat and trace metals speed up. The dry solid reacts at exposed surfaces, and a solution reacts throughout. NAD+ has no such return path without a reductant, but water attacks it hydrolytically, faster as temperature rises and as pH leaves the mildly acidic range.

pH is where the two profiles cross. The NAD+ catalog gives a 1% solution at pH 2.0–4.0, where the oxidised form is comparatively comfortable; NADH is acid-labile and is normally handled at alkaline pH. A low-pH drink therefore favours the oxidised form, while a high-pH drink is no long-term home for either. Reformulating from one to the other means repeating the pH, hold-time and appearance work, not editing a number.

Both solids are hygroscopic. The pack has to exclude water and light for either one, and a stability file written for one form says nothing about the other.

Converting mass is not converting the ingredient

The ingredient name has to identify the redox state and, for NADH, the salt as well. “Reduced nicotinamide adenine dinucleotide disodium salt” is not the same declaration as “β-nicotinamide adenine dinucleotide”, and “NAD” on its own is ambiguous. The declared quantity and the assay basis should use the same form and the same units as the specification.

Ten milligrams of NADH disodium contains 9.38 mg of the free-acid moiety (10 × 665.45 ÷ 709.40); the remainder is the two sodium ions less the two protons they replace. On a pure free-acid comparison, 10 mg of NADH is 10.03 mg of NAD+ equivalent, because the reduced molecule carries two extra hydrogen atoms. Those factors describe mass, not interchangeability.

Whether a market file covers the label is a separate question. A file written for one form is not automatically valid for the other, and the buyer's regulatory team has to confirm the route for the destination. No authorisation is asserted here for either form.

Which form the project should buy

Pick NADH when the label, specification and market file all name the reduced form; buy the disodium salt with a 340 nm assay, a loss on drying limit and a sodium check. Pick NAD+ when the oxidised form is named and the product is dry. An assay figure alone does not settle the choice.

Switching to fit a supplier quotation, an old specification or a label translation is still a formulation change. It moves the CAS number, the detection wavelength, the stability risks and the regulatory citation together, so it needs a change control, a new certificate and a fresh label review.

NADH is not NMN or nicotinamide riboside either; those are separate molecules with their own specifications. Catalog data is on the NADH product page, the oxidised material has its own NAD+ page, the separation is covered in the HPLC method note, and the release file is described on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation